Genexine

Developer of immunotherapeutics for treating orphan diseases, cancers & autoimmune disorders

placeSeongnam-si, Gyeonggi-do, South Korea calendar_todayFounded 2002 language genexine.com

Innovation

77 patent families (26 granted) — focus: Chemistry & metallurgy, Human necessities, Emerging technologies, Construction; filing pace slowing. Cited 2,801 times.

YearFilings
20146
20156
20168
201716
201817
20198
202010
202124
202218
202317
202413
202516

Social engagement

Social engagement: 1.5K social following, 5 posts in the last 12 months — below the industry typical range.

Investor mix

6 investors on record; 1 has since exited.

Investor typeCountShare
Venture capital467%
Private equity233%

Recent activity

12 Nov 2025
Event
Incheon #RNA-Based Therapeutics & Vaccine Summit Asia
7 Jul 2025
Event
5th Annual mRNA-Based Therapeutics Summit
Coming soon